YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

Australian Research Institute IDs Novel Syndrome Variants with NextCODE Tools

June 23, 2014 | The ANZAC Research Institute in Sydney, Australia, has used NextCODE Health's Clinical Sequence Analyzer and Sequence Miner tools to ID novel sequence variants behind X-linked Charcot-Marie-Tooth syndrome (CMTX). "NextCODE's platform has enabled us to use whole-genome sequencing to identify variants never before linked to CMTX," said Dr Marina Kennerson, a principle research fellow at ANZAC in a NextCODE press release. The two tools are part of a suite of NextCODE offerings that were born from deCODE's data architecture. NextCODE Press Release
Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.